bendamustine hydrochloride has been researched along with Breast Neoplasms in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (5.26) | 18.7374 |
1990's | 3 (15.79) | 18.2507 |
2000's | 10 (52.63) | 29.6817 |
2010's | 3 (15.79) | 24.3611 |
2020's | 2 (10.53) | 2.80 |
Authors | Studies |
---|---|
Chen, Y; Hu, R; Huang, X; Li, C; Niu, MM; Tan, Y; Zhou, Y | 1 |
Ballestrero, A; Calabrese, M; Ceccardi, A; Cuccarolo, P; Dameri, M; Garlaschi, A; Gristina, L; Stabile, M; Tagliafico, A; Valente, I; Zoppoli, G | 1 |
Bingman, A; Carothers, S; Kraut, EH; Layman, RM; Lustberg, MB; Lynn, M; Mrozek, E; Ottman, S; Ramaswamy, B; Reinbolt, R; Ruppert, AS; Shapiro, CL; Wesolowski, R | 1 |
Chinnaiyan, P; Neuger, A; Pan, E; Smith, P; Yu, D; Yu, HH; Zhao, X | 1 |
Heinrich, G; Loibl, S; Müller, L; Murmann, C; Nekljudova, V; Schwedler, K; von Minckwitz, G; Warm, M | 1 |
Linder, M; Loibl, S; von Minckwitz, G | 1 |
Frost, A; Häring, B; Mross, K; Steinbild, S; Unger, C | 1 |
Alam, S; Layman, R; Lustberg, M; Reinbolt, RE; Shapiro, C | 1 |
Höffken, K; Klippstein, A; Sayer, HG; Schneider, CP | 1 |
Chernozemsky, I; Chilingirov, P; Fritze, D; Kaufmann, M; Kleeberg, U; Loibl, S; Marschner, N; Merkle, Kh; Sirakova, L; Souchon, R; Stuart, N; Thomssen, C; Tsekov, C; Vermorken, JB; von Minckwitz, G | 1 |
Eichbaum, MH; Foerster, F; Khbeis, T; Lauschner, I; Schneeweiss, A; Schuetz, F; Sohn, C | 1 |
Bamberg, M; Bokemeyer, C; Huober, J; Reichmann, U; Wallwiener, D | 1 |
Doll, K; Harstrick, A; Hoffmann, B; Seeber, S; Strumberg, D | 1 |
Anger, G; Brandtner, M; Höffken, K; Merkle, K; Ridwelski, K; Schönfelder, M; Seeber, S | 1 |
Ruffert, K | 1 |
Balfour, JA; Goa, KL | 1 |
Höffken, K; Kath, R; Merkle, K; Semrau, R; Zulkowski, K | 1 |
Berger, MR; Genova, M; Konstantinov, SM; Kostovski, A; Topashka-Ancheva, M | 1 |
Brockmann, B; Geschke, E; Kirchhof, I; Schmidt, UM | 1 |
1 review(s) available for bendamustine hydrochloride and Breast Neoplasms
Article | Year |
---|---|
Bendamustine.
Topics: Antineoplastic Agents; Bendamustine Hydrochloride; Breast Neoplasms; Female; Half-Life; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Metabolic Clearance Rate; Nitrogen Mustard Compounds | 2001 |
9 trial(s) available for bendamustine hydrochloride and Breast Neoplasms
Article | Year |
---|---|
Severe and prolonged lymphopenia observed in patients treated with bendamustine and erlotinib for metastatic triple negative breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Breast Neoplasms; CD4 Lymphocyte Count; Dose-Response Relationship, Drug; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Lymphopenia; Middle Aged; Neoplasm Metastasis; Nitrogen Mustard Compounds; Quinazolines; Severity of Illness Index | 2013 |
Phase I study of bendamustine with concurrent whole brain radiation therapy in patients with brain metastases from solid tumors.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Brain Neoplasms; Breast Neoplasms; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Combined Modality Therapy; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Maximum Tolerated Dose; Melanoma; Middle Aged; Nitrogen Mustard Compounds; Survival Analysis; Treatment Outcome | 2014 |
Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer: RiTa trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bone Neoplasms; Breast Neoplasms; Disease-Free Survival; Dose-Response Relationship, Drug; Feasibility Studies; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Nitrogen Mustard Compounds; Paclitaxel; Pleural Neoplasms; Survival Rate; Treatment Outcome | 2009 |
Phase II STUdy with 3rd- or 4th-line bendamustine (flat dose) therapy in patients with metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Bendamustine Hydrochloride; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Germany; Humans; Middle Aged; Nitrogen Mustard Compounds; Treatment Outcome | 2009 |
Bendamustine prolongs progression-free survival in metastatic breast cancer (MBC): a phase III prospective, randomized, multicenter trial of bendamustine hydrochloride, methotrexate and 5-fluorouracil (BMF) versus cyclophosphamide, methotrexate and 5-fluo
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Nitrogen Mustard Compounds; Prospective Studies; Survival Rate; Time Factors; Treatment Outcome | 2005 |
Weekly administration of bendamustine as salvage therapy in metastatic breast cancer: final results of a phase II study.
Topics: Adult; Aged; Antineoplastic Agents; Bendamustine Hydrochloride; Breast Neoplasms; Disease-Free Survival; Female; Follow-Up Studies; Genes, erbB-2; Hematologic Diseases; Humans; Middle Aged; Neoplasm Metastasis; Nitrogen Mustard Compounds; Salvage Therapy; Survival Analysis | 2007 |
Salvage chemotherapy for metastatic breast cancer: results of a phase II study with bendamustine.
Topics: Adult; Aged; Antineoplastic Agents; Bendamustine Hydrochloride; Breast Neoplasms; Female; Humans; Middle Aged; Neoplasm Metastasis; Nitrogen Mustard Compounds; Salvage Therapy | 2007 |
Bendamustine as salvage treatment in patients with advanced progressive breast cancer: a phase II study.
Topics: Adult; Aged; Antineoplastic Agents; Bendamustine Hydrochloride; Breast Neoplasms; Humans; Middle Aged; Neoplasm Metastasis; Nitrogen Mustard Compounds; Pilot Projects; Salvage Therapy; Treatment Outcome | 1998 |
[Primary chemotherapy of metastatic breast carcinoma with bendamustine hydrochloride, methotrexate and fluorouracil versus cyclophosphamide, methotrexate and fluorouracil].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Methotrexate; Neoplasm Metastasis; Nitrogen Mustard Compounds; Pilot Projects; Salvage Therapy; Survival Rate; Treatment Outcome | 1998 |
9 other study(ies) available for bendamustine hydrochloride and Breast Neoplasms
Article | Year |
---|---|
A Supramolecular Nanomedicine Based on Bendamustine and MDM2-Targeted D-peptide Inhibitor for Breast Cancer Therapy.
Topics: Animals; Bendamustine Hydrochloride; Breast Neoplasms; Female; Humans; MCF-7 Cells; Mice; Mice, Nude; Nanomedicine; Peptides; Proto-Oncogene Proteins c-mdm2 | 2021 |
Complete pathological response of hormone receptor positive invasive breast cancer in a patient with multiple myeloma treated with ixazomib.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Breast Neoplasms; Dexamethasone; Female; Humans; Multiple Myeloma; Neoplasm Recurrence, Local; Recurrence | 2023 |
The reawakening of bendamustine - also in breast cancer?
Topics: Antineoplastic Agents; Bendamustine Hydrochloride; Breast Neoplasms; Evidence-Based Medicine; Germany; Humans; Medical Oncology; Nitrogen Mustard Compounds; Practice Patterns, Physicians' | 2009 |
Pneumocystis jiroveci Pneumonia in an Atypical Host.
Topics: Adrenal Cortex Hormones; Anti-Infective Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bevacizumab; Breast Neoplasms; CD4 Lymphocyte Count; Clinical Trials, Phase I as Topic; Dexamethasone; Erlotinib Hydrochloride; Female; Humans; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Nitrogen Mustard Compounds; Paclitaxel; Pneumocystis carinii; Pneumonia, Pneumocystis; Quinazolines; Trimethoprim, Sulfamethoxazole Drug Combination | 2012 |
Pneumocystis carinii pneumonia as a complication of bendamustine monotherapy in a patient with advanced progressive breast cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Breast Neoplasms; Carcinoma, Ductal, Breast; Drug Administration Schedule; Fatal Outcome; Female; Humans; Leukopenia; Middle Aged; Nitrogen Mustard Compounds; Pneumonia, Pneumocystis; Respiratory Insufficiency; Treatment Failure | 2003 |
Bendamustine hydrochloride activity against doxorubicin-resistant human breast carcinoma cell lines.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Breast Neoplasms; Carmustine; Cisplatin; Cyclophosphamide; DNA Damage; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Melphalan; Nitrogen Mustard Compounds; Ovarian Neoplasms; Tumor Cells, Cultured | 1996 |
Regression of brain metastases from breast carcinoma after chemotherapy with bendamustine.
Topics: Adult; Antineoplastic Agents; Bendamustine Hydrochloride; Brain Neoplasms; Breast Neoplasms; Female; Humans; Liver Neoplasms; Nitrogen Mustard Compounds; Treatment Outcome | 2002 |
Cytotoxic efficacy of bendamustine in human leukemia and breast cancer cell lines.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bendamustine Hydrochloride; Bone Marrow Cells; Breast Neoplasms; Flow Cytometry; HL-60 Cells; Humans; Leukemia; Mice; Nitrogen Mustard Compounds; Tumor Cells, Cultured | 2002 |
[Therapeutic results and toxic side effects of the combination cytostasan, adriamycin and vincristine as second-line therapy of metastatic breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Nitrogen Mustard Compounds; Remission Induction; Vincristine | 1989 |